Drug Prices: So Much For Restraint
In "Drug prices: So much for restraint" (News: Analysis & Commentary, Mar. 4), the 1.7% rise in drug prices last year was measured at the producer and wholesaler level, not the consumer level.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.